Effect of altered lymphocyte function on immunologic disorders in nzb/nzw mice
โ Scribed by Jagdish Mehta; Linda L. Knotts; Bevra H. Hahn
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 614 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
NZB/NZW F~1~ female mice were treated with the immunosuppressive enzyme Lโasparaginase (Asnase) for up to 32 weeks. Asnase diminished circulating antiโDNA and antinuclear antibodies, diminished deposition of ฮณโglobulins in kidneys, significantly delayed the onset of proteinuria, and reduced deaths from nephritis. These effects were associated with reduction of cellular IgM antibody synthesis to both Tโdependent and Tโindependent antigens, but the graftโversusโhost reaction was not affected. After several weeks of therapy, antibodies against Asnase appeared in the circulation, the effect on antibody synthesis was lost, ANA and antiโDNA appeared, followed by proteinuria and deaths from nephritis. Therefore Asnase proved to be an effective therapy in NZB/NZW mice, but its usefulness was limited by the appearance of inactivating antibodies.
๐ SIMILAR VOLUMES
## Abstract NZB/NZW F~1~ female mice received levamisole in an attempt to increase suppressor T cell function. Responses varied with dosage of drug and age of mice. When treatment with 25 ฮผg/gm doses (intermittent or daily) was begun at 12 weeks of age, nephritis was accelerated in spite of transie
## Objective: This study examined the interactions between exogenous and endogenous factors shaping the phenotype of lupus in autoimmune (nzb x nzw)f(1) mice exposed to pristane, a model environmental trigger. ## Methods: Frequencies of various autoantibodies in untreated nzb/nzw mice were determ
## Abstract This investigation examined the effect of retinoic acid on tumor progression and immunological status of mice bearing the B16โF10 melanoma (previously selected for high lungcolonizing capacity). Tumor cells were implanted s. c. in syngeneic C57BL/6 mice, half of which were treated with